NCT00514969View on ClinicalTrials.gov

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG

Imatinib (STI571)

Trial Locations (1)

Unknown

"Istituto di Ematologia e Oncologia Medica L. e A. Seràgnoli Università degli Studi di Bologna", Bologna

All Listed Sponsors

lead

University of Bologna

OTHER

NCT00514969 - Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase | Biotech Hunter | Biotech Hunter